{"title":"Monitoring and Improving Time to Treatment for Syphilis.","authors":"Aaryan Midha, Jeffrey D Klausner","doi":"10.1097/OLQ.0000000000002355","DOIUrl":"10.1097/OLQ.0000000000002355","url":null,"abstract":"","PeriodicalId":21837,"journal":{"name":"Sexually transmitted diseases","volume":" ","pages":"e74-e75"},"PeriodicalIF":1.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147875622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
River Pugsley, Nicole Barron, Oana Vasiliu, Sulola Adekoya
{"title":"Extragenital testing for gonorrhea and chlamydia in health department clinics in Virginia, 2018-2023.","authors":"River Pugsley, Nicole Barron, Oana Vasiliu, Sulola Adekoya","doi":"10.1097/OLQ.0000000000002394","DOIUrl":"https://doi.org/10.1097/OLQ.0000000000002394","url":null,"abstract":"<p><strong>Background: </strong>Extragenital testing for chlamydia and gonorrhea infections is now routine in many settings. We assessed temporal and demographic trends in extragenital testing and positivity in public health department clinics in Virginia.</p><p><strong>Methods: </strong>We analyzed urogenital and extragenital chlamydia/gonorrhea laboratory results for clients aged 15 years or older who attended 116 health department clinics from 2018 to 2023. Test volume and positivity was stratified by anatomic site, year, sex, and age.</p><p><strong>Results: </strong>There were 181,471 client visits with valid test results. The proportion of visits with any extragenital testing increased from 19% to 46% during this time. Male clients were twice as likely as females to receive pharyngeal testing (46% vs. 22%) and five times as likely to be tested rectally (15% vs. 3%). Rectal specimen positivity surpassed urogenital positivity for chlamydia (females and males) and gonorrhea (males only). Overall, one-quarter of clients diagnosed with gonorrhea infections were identified exclusively through extragenital testing, as were 9% of clients with positive chlamydia tests. These proportions increased over time and were greater for younger clients and for males relative to females. Two-thirds of extragenital infections would have been missed by urogenital testing alone, including 40% and 49% of females and 86% and 73% of males with extragenital chlamydia and gonorrhea infections respectively.</p><p><strong>Conclusions: </strong>The proportion of clients who received extragenital chlamydia/gonorrhea testing increased over time, extragenital test positivity was high, and it identified infections that would have been missed otherwise. The impact on sexually transmitted infection sequelae and transmission remains unclear.</p>","PeriodicalId":21837,"journal":{"name":"Sexually transmitted diseases","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148874924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Carissa K Harvest, Rebecca S Treger, Timothy W Menza, Christopher T Buresh, Giannoula S Tansarli, Lori Bourassa, Anjelica Ludwig, Ferric C Fang, Thao T Truong
{"title":"Utilization and Performance of a Rapid Treponemal Antibody Test for Diagnosis of Syphilis in a High-Risk Population at an Urban County Hospital.","authors":"Carissa K Harvest, Rebecca S Treger, Timothy W Menza, Christopher T Buresh, Giannoula S Tansarli, Lori Bourassa, Anjelica Ludwig, Ferric C Fang, Thao T Truong","doi":"10.1097/OLQ.0000000000002352","DOIUrl":"10.1097/OLQ.0000000000002352","url":null,"abstract":"<p><strong>Background: </strong>Rapid detection of syphilis infection enables timely antibiotic treatment to prevent long-term complications and further transmission. We implemented a treponemal rapid lateral flow immunochromatographic test that was performed by trained clinical laboratory personnel on a 24/7 basis in an urban county hospital.</p><p><strong>Methods: </strong>From March 2023 to February 2024, 461 rapid syphilis tests (RSTs) were performed on serum from 449 patients. Specimens were also tested by a conventional reverse algorithm beginning with an enzyme immunoassay, followed by a rapid plasma reagin test, and when necessary, an additional treponemal test to resolve discordant results.</p><p><strong>Results: </strong>Most patients (349, 77.7%) initially presented to the emergency department. The most common patient risk factors for syphilis were substance use disorder (51.9%) and unstable housing (42.8%). Compared with the reverse algorithm, rapid syphilis test (RST) sensitivity was 52.2%, specificity 98.2%, positive predictive value 83.7%, and negative predictive value 92.1%. After excluding 45 patients who had a documented prior history of syphilis, RST sensitivity was 83.3%, specificity 98.2%, positive predictive value 74.1%, and negative predictive value 99.0%. Nearly all of the 33 patients testing negative by the RST but positive by enzyme immunoassay were more likely to have been treated for a previous infection: 27 had a documented history of treatment, and 30 had undetectable or low rapid plasma reagin titers (≤1:2). The median RST turnaround time was 1.6 hours compared with 197.8 hours for reverse algorithm screening.</p><p><strong>Conclusions: </strong>RST is a useful option for high-risk patients in urban settings. Other testing methods are preferable for previously treated syphilis, and conventional follow-up testing is required to confirm results.</p>","PeriodicalId":21837,"journal":{"name":"Sexually transmitted diseases","volume":" ","pages":"619-625"},"PeriodicalIF":1.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13440538/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147975624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xinru Tsai, Bow Suprasert, Erin C Wilson, Willi McFarland
{"title":"Shigellosis Awareness and Diagnosis in Community Surveys of Men Who Have Sex With Men and Trans Women, San Francisco, California, United States.","authors":"Xinru Tsai, Bow Suprasert, Erin C Wilson, Willi McFarland","doi":"10.1097/OLQ.0000000000002311","DOIUrl":"10.1097/OLQ.0000000000002311","url":null,"abstract":"<p><strong>Background: </strong>Shigellosis has increasingly and disproportionately affected sexual and gender minority populations. Although historically considered a food- and waterborne illness, Shigella can also be transmitted sexually. This study assessed awareness of shigellosis among men who have sex with men (MSM) and trans women and examined the burden of infection and treatment among MSM in San Francisco.</p><p><strong>Methods: </strong>Data were drawn from the most recent National HIV Behavioral Surveillance cycles conducted among MSM (June-November 2023) and trans women (July 2023-May 2024) in San Francisco. The MSM cycle included 3 Shigella-related items (awareness, history of diagnosis, and treatment), while the trans women cycle included 2 items (past and recent history of diagnosis). Multivariable logistic regression was conducted to examine factors associated with shigellosis awareness among MSM.</p><p><strong>Results: </strong>Among 545 MSM, 35.4% were aware of shigellosis, 5.5% reported ever having the infection, and 5.1% sought treatment. Among 339 trans women, 1.2% reported ever having shigellosis and 0.3% within the past 12 month. Among MSM, awareness was higher among White participants, those with postgraduate education, those who saw a healthcare provider, and those who tested positive for a bacterial sexually transmitted infection in the past 12 month.</p><p><strong>Conclusions: </strong>Despite global outbreaks among MSM, awareness of shigellosis within sexual and gender minority communities remains low, and the burden of infection is likely underestimated. Tailored, stigma-sensitive sexual health promotion integrating shigellosis into broader sexually transmitted infection prevention efforts, alongside improved provider training, is essential to ensure equitable care and reduce future outbreak risk.</p>","PeriodicalId":21837,"journal":{"name":"Sexually transmitted diseases","volume":" ","pages":"660-663"},"PeriodicalIF":1.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147594862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gabriela S Betancourt, Diana M Sanchez, Zachary Heth, Em Pike, Carlos Cubas
{"title":"What do Providers and Community Members Think About Disease Intervention Specialists?: Provider and Community Member Assessments in New York City.","authors":"Gabriela S Betancourt, Diana M Sanchez, Zachary Heth, Em Pike, Carlos Cubas","doi":"10.1097/OLQ.0000000000002358","DOIUrl":"10.1097/OLQ.0000000000002358","url":null,"abstract":"<p><strong>Background: </strong>Disease intervention specialists (DIS) effectively interrupt population-level spread of diseases including sexually transmitted infections. Healthcare provider and patient engagement is critical to DIS' success. Few studies have examined attitudes towards DIS among these groups.</p><p><strong>Methods: </strong>We invited 634 providers from STI, human immunodeficiency virus, and viral hepatitis partnerships with the New York City (NYC) Health Department and 412 members of a NYC Health Department-led community advisory group, to take provider and community surveys regarding awareness, perceptions, and experiences with DIS. Results were summarized across surveys by shared themes: awareness of DIS' role, experiences with DIS, and perceptions of DIS.</p><p><strong>Results: </strong>Provider and community surveys yielded 73 and 86 responses, respectively, for response rates of 11.5% and 20.9%. Provider and community awareness of DIS responsibilities were as follows: partner notification, 74.0% (provider survey) and 89.5% (community survey); linkage to care, 72.6% and 92.1%; partner services, 69.9% and 86.8%. Confidentiality was the top barrier noted by providers (16.4%). Among community respondents, 13.1% and 23.7% incorrectly believed DIS could disclose identifying health information to a patient's neighbors or friends, or to law enforcement, respectively. Overall, 56 providers and 44 community respondents had previous DIS interactions; of those, 78.8% and 74.4% reported positive experiences.</p><p><strong>Conclusions: </strong>In our modest sample or urban providers and community members, we observed high overall awareness of DIS responsibilities though lower for providers. Community findings suggest misperceptions about DIS relating to confidentiality and privacy of health information. Education to clarify and boost awareness of DIS may increase comfort, trust, and engagement.</p>","PeriodicalId":21837,"journal":{"name":"Sexually transmitted diseases","volume":" ","pages":"643-649"},"PeriodicalIF":1.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13440543/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148056875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Estimating Excess Mortality Among People Living with Human Immunodeficiency Virus During the Coronavirus Disease 2019 Pandemic in the United States.","authors":"Lindsay M Hall, Hamed Karami, Gerardo Chowell","doi":"10.1097/OLQ.0000000000002345","DOIUrl":"10.1097/OLQ.0000000000002345","url":null,"abstract":"<p><strong>Background: </strong>Understanding the syndemic effects of COVID-19 and Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome can inform future public health preparedness. This study quantifies the all-cause excess death rate (EDR) of people living with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (PWHA) during the 2020 to 2022 COVID-19 pandemic in the United States, including stratifications by sex, age, race/ethnicity, and region.</p><p><strong>Methods: </strong>Using publicly available data from the CDC AtlasPlus dashboard, we employed an ensemble n-subepidemic modeling framework ( SubEpiPredict toolbox). This dynamic parametric approach is well-suited for counterfactual forecasting with relatively short time series and was used to generate expected deaths among PWHA for 2020 to 2022 based on pre-pandemic trends. The models were calibrated using 12 years of pre-pandemic mortality trends (2008-2019), with the median EDR calculated as observed minus forecasted death rates.</p><p><strong>Results: </strong>Overall excess mortality among PWHA was estimated at 7783 crude excess deaths (95% prediction interval: 5098-10,525), corresponding to 2.77 excess deaths per 100,000 people (95% prediction interval: 1.81-3.75), with the largest burden observed in 2021. EDRs were highest among males (3.39), age 55 to 64 (4.94), multiracial (12.82), and Northeast (4.12) groups. The largest crude number of excess deaths occurred among males (4692), aged 65 years and older (2560), Black/African Americans (3969), and Southern (4025) groups.</p><p><strong>Conclusions: </strong>These systematic, model-based results reveal stark heterogeneities among PWHA by exposing recent mortality patterns that may not be captured by disease-specific mortality reporting alone. These findings provide a robust, reproducible benchmark for assessing pandemic-related disparities and can inform future public health resource allocation and tailored interventions for vulnerable populations.</p>","PeriodicalId":21837,"journal":{"name":"Sexually transmitted diseases","volume":" ","pages":"650-659"},"PeriodicalIF":1.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147875612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sharon L Hillier, Ingrid Macio, Rachel Gallagher, Leslie Meyn, May Beamer, Tracy Zamborsky, Tracy Campbell, Katherine Bunge, Harold C Wiesenfeld
{"title":"Randomized Study of Usual Care Versus Xpert ® Xpress Multiplex Vaginal Panel at the Point-of-Care for Accurate Diagnosis and Appropriate Treatment of Vaginal Infections.","authors":"Sharon L Hillier, Ingrid Macio, Rachel Gallagher, Leslie Meyn, May Beamer, Tracy Zamborsky, Tracy Campbell, Katherine Bunge, Harold C Wiesenfeld","doi":"10.1097/OLQ.0000000000002343","DOIUrl":"10.1097/OLQ.0000000000002343","url":null,"abstract":"<p><strong>Background: </strong>The accuracy of vaginitis diagnoses in usual care varies. This study ( clinicaltrials.gov NCT06438575) evaluated the clinical utility of Xpert ® Xpress Multiplex Vaginal Panel, a Clinical Laboratory Improvement Amendments-waived nucleic acid amplification test (NAAT), for the diagnosis of vaginal infections at the point-of-care (POC).</p><p><strong>Methods: </strong>Women (n = 276) seeking care for vaginal symptoms (discharge, odor, itch, irritation, and discomfort) provided self-collected vaginal samples and were randomized to usual care or POC NAAT. True positives were defined as samples positive for bacterial vaginosis (BV), Candida , or Trichomonas vaginalis (TV) by two concordant Food and Drug Administration-cleared NAATs. The primary endpoint was the proportion of women prescribed appropriate Centers for Disease Control recommended or Food and Drug Administration-approved treatment for the identified conditions within 24 hours of the visit. Groups were compared using Fisher exact test.</p><p><strong>Results: </strong>Median participant age was 33 years (range 17-76), with self-reported race of 50% Black, 41% White, and 9% other. Twenty (7%) participants were pregnant. The prevalence of BV, Candida , and TV was 44.7%, 32.0%, and 5.1%, respectively, and 36.9% of women had no pathogens detected. For women having BV, TV, or Candida , 40/77 (51.9%) of the usual care arm received appropriate treatment versus 69/77 (89.6%) of women in the POC NAAT arm ( P < 0.001). Among women without pathogens, 21/42 (50.0%) were inappropriately treated with antifungals or antibiotics in the usual care arm versus 13/48 (27.1%) in the POC NAAT arm ( P = 0.031).</p><p><strong>Conclusion: </strong>POC NAATs have clinical utility for the diagnosis of women with vaginal symptoms, increasing the likelihood of appropriate treatment and reducing over-treatment of women without pathogens compared with usual care.</p>","PeriodicalId":21837,"journal":{"name":"Sexually transmitted diseases","volume":" ","pages":"589-595"},"PeriodicalIF":1.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13440600/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147875624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nicole L Gallaway, David A Jackson, Elizabeth Torrone
{"title":"Timeliness of Treatment Initiation Among US Syphilis Cases in 2023.","authors":"Nicole L Gallaway, David A Jackson, Elizabeth Torrone","doi":"10.1097/OLQ.0000000000002339","DOIUrl":"10.1097/OLQ.0000000000002339","url":null,"abstract":"<p><p>Timely treatment of syphilis is key to interrupting transmission and preventing sequelae. We calculated treatment timeliness for reported syphilis cases in the United States in 2023. Most case notifications (85.6%) had documentation of starting treatment within 6 months, with variations in days to treatment initiation by syphilis stage, sex, and pregnancy status.</p>","PeriodicalId":21837,"journal":{"name":"Sexually transmitted diseases","volume":" ","pages":"e70-e73"},"PeriodicalIF":1.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13321068/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147843109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dorothy Apedaile, Kelika A Konda, Jesus Batista, Juan Carlos Ramirez Tovar, Julien Brisson, Deana Franceska De Jesus Léon Morris, Mariangela Castro-Arteaga, Valeria Fulqui Patriarca, Silver K Vargas, Alfonso Silva Santisteban, Amaya Perez-Brumer
{"title":"HIV and STI Co-infection and Migration-Related Social Vulnerability among Venezuelan Gay and Bisexual Migrants in Lima, Peru.","authors":"Dorothy Apedaile, Kelika A Konda, Jesus Batista, Juan Carlos Ramirez Tovar, Julien Brisson, Deana Franceska De Jesus Léon Morris, Mariangela Castro-Arteaga, Valeria Fulqui Patriarca, Silver K Vargas, Alfonso Silva Santisteban, Amaya Perez-Brumer","doi":"10.1097/OLQ.0000000000002403","DOIUrl":"https://doi.org/10.1097/OLQ.0000000000002403","url":null,"abstract":"<p><strong>Background: </strong>This study examined HIV, bacterial STI co-infection, and migration-related vulnerability among Venezuelan gay, bisexual, and other men who have sex with men (GBM) in Lima, Peru.</p><p><strong>Methods: </strong>A total of 306 Venezuelan GBM of any serostatus living in Lima, Peru, were recruited between June and October 2024 for a cross-sectional biobehavioural survey with laboratory-based testing for HIV, chlamydia and syphilis. Poisson regression models with robust standard errors were used to estimate the association between HIV status, migration context, and STI positivity.</p><p><strong>Results: </strong>The median age of participants was 32 years, and 59% had been living in Peru since 2018 or earlier. Overall, 152 GBM were living with HIV, of whom 70 were diagnosed with HIV in Venezuela, 65 after leaving, and 17 newly diagnosed through the study. Almost all (99%) GBM living with HIV who knew their status reported being on ART. The most common STI was syphilis (19%), followed by gonorrhea (12%) and chlamydia (10%). Compared to HIV negative GBM, those diagnosed with HIV in Venezuela (PR=2.29 95% CI: 1.39-3.79) and after leaving Venezuela (PR=22.29 95% CI: 1.47-3.56) were more likely to test positive for an STI.</p><p><strong>Conclusions: </strong>Venezuelan GBM migrants in Lima experience both high HIV care engagement and an ongoing burden of STIs within a broader context of migration-related social vulnerability. While Peru's HIV infrastructure demonstrates capacity for post-migration linkage to care, persistent STI co-infection and migration-related treatment disruptions highlight the need for more integrated and sustained HIV-STI prevention, sexual health services, and resettlement support.</p>","PeriodicalId":21837,"journal":{"name":"Sexually transmitted diseases","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148840987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Healthcare Providers' Interest in Receiving Sexually Transmitted Infection Training-DocStyles Survey, United States, Fall 2024.","authors":"Guoyu Tao, Alexandra Coor, Lindley A Barbee","doi":"10.1097/OLQ.0000000000002402","DOIUrl":"https://doi.org/10.1097/OLQ.0000000000002402","url":null,"abstract":"<p><strong>Background: </strong>There is limited evidence assessing healthcare providers' interest in sexually transmitted infection (STI) training in the United States (US).</p><p><strong>Methods: </strong>Five STI-related questions were included in the Fall 2024 DocStyles survey, a US national, semi-annual web-based survey of healthcare providers. The study sample consisted of 1,501 providers: 1,001 primary care physicians (PCPs); 250 obstetricians/gynecologists (OB/GYNs); and 250 nurse practitioners and physician assistants (NP/PAs). Bivariate analyses and multiple logistic models were used to identify factors statistically associated with interest in STI training (p<0.05).</p><p><strong>Results: </strong>About 45.2% of 1501 providers provided >10% of their patients with STI services (36.9% among PCPs, 88.4% among OB/GYNs, and 35.6% among NP/PAs). Only 17.1% reported receiving specialized STI training beyond residency or fellowship. Nearly half (48.2%) reported to be very or extremely interested in receiving STI training (47.6% of PCPs, 56.0% of OB/GYNs, and 42.8% of NP/PAs). Providers were more likely to be interested in STI training if they were female, Hispanic, non-Hispanic Black, or non-Hispanic Asian, had 3-19 years of practice (compared with 30 or more years), cared for more than 50 patients per week, provided >10% of their patients with STI services (versus less than 10%), and had received specialized STI training beyond residency or fellowship.</p><p><strong>Conclusion: </strong>Our findings suggest ongoing demand for STI training for US healthcare providers. More targeted and effective outreach strategies are needed to reach providers who may be less likely to access this training, including primary care physicians and nurse practitioners/physician assistants.</p>","PeriodicalId":21837,"journal":{"name":"Sexually transmitted diseases","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2026-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148819478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}